alcoholic liver disease
Start with the big picture
ALD ranges from potentially reversible fat accumulation in the liver to inflammatory alcoholic hepatitis and advanced cirrhosis. Its development involves alcohol-related cellular injury, oxidative stress, inflammatory signaling, and gut-derived endotoxin. Laboratory patterns can support clinical assessment, while severity scores help identify patients at greater risk and inform treatment decisions. Imaging can demonstrate fatty change and help assess fibrosis; biopsy may be used when the diagnosis is uncertain. Management centers on sustained alcohol abstinence, alongside nutritional support and careful treatment of severe hepatitis and cirrhosis-related complications. The full lesson connects these principles with medication safety, preventive care, and the pharmacist’s role in supporting patients.
What you'll learn
- Describe the progressive stages of alcoholic liver disease.
- Explain key mechanisms contributing to liver injury in ALD.
- Recognize laboratory, imaging, and severity-assessment approaches.
- Summarize core management priorities and complication-prevention themes.
- Identify medication-safety and preventive-care considerations in ALD.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
